BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Guardant Health’s Shield™ Blood Test for Colorectal Cancer Screening Recommended for FDA Approval

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Molecular and Clinical Genetics Panel of...

May 27, 2024 | News

Lunit Completes Acquisition of Volpara Health Technologies, Enhancing AI-Driven Cancer Diagnostics

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, proudly announces the successful completion of i...

May 23, 2024 | News

Aptamer Group Signs £465,000 Agreement for Development of Cervical Cancer Blood Test

Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...

May 22, 2024 | News

Envac Wins €10 Million Contracts to Enhance Waste Management in French Hospitals

Smart waste management in hospitals has been increasingly important for achieving the higher standards of safety and environmental expectation required by ...

May 22, 2024 | News

RemeGen Announces Completion of Patient Enrollment for Two Phase III Clinical Trials of Telitacicept in China

RemeGen Co. a commercial-stage biotechnology company, recently announced significant progress of Telitacicept (RC18), that two Phase III clinical tria...

May 22, 2024 | News

Medtronic Announces Positive Results for Sphere-9™ Catheter in Treating Persistent AFib

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced positive results demonstrating the excellent safety and effica...

May 20, 2024 | News

Serum Institute of India Acquires 20% Stake in IntegriMedical to Accelerate Development of Needle-Free Injection Technology

- With this investment, SII will acquire 20% stake in IntegriMedical - ...

May 20, 2024 | News

Amgen's IMDELLTRA™ Approved for Aggressive Lung Cancer

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with e...

May 17, 2024 | News

Baxter International Announces Mission and Logo for Proposed Kidney Care Company, Vantive

The Vantive mission, "Extending Lives, Expanding Possibilities," will guide and inspire the proposed company, which will focus on vital organ therapies for...

May 16, 2024 | News

A&D Invests $1M in Aevice Health to Expand Remote Respiratory Solutions

A&D Company, Limited has entered into a US$1M investment agreement with Aevice Health The collaboration is geared towards jointly expand...

May 15, 2024 | News

Fujitsu Develops Advanced AI to Transform Medical Diagnostics with Multimodal Data Integration

Fujitsu announced the development of explainable AI technology that automatically draws on data in multiple formats, including text, images, and nume...

May 13, 2024 | News

Arcellx and Kite Announce Phase 3 Trial for Anito-cel in Multiple Myeloma Patients

-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMi...

May 10, 2024 | News

GHIT Fund Allocates JPY 1.64 Billion to Combat Malaria and Neglected Tropical Diseases Through Innovative Partnerships

The Global Health Innovative Technology (GHIT) Fund announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...

May 09, 2024 | News

GE HealthCare Introduces SIGNA MAGNUS, Pioneering Head-Only MRI Scanner for Neuroscience Breakthroughs

GE HealthCare unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, whic...

May 06, 2024 | News

Stay Connected